Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease

International Urology and Nephrology

Volumn 44, Issue 1, 2012, Pages 167-171

  Pipili, Chrysoula ^a   Dimitriadis, Chrysostomos ^a   Sekercioglu, Nigar ^a   Bargman, Joanne M ^a   Oreopoulos, Dimitrios D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CINACALCET; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR;

ADIPOSE TISSUE; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; FRACTURE; GLUCOSE INTOLERANCE; HUMAN; HYPOCALCEMIA; HYPOPHOSPHATEMIA; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PARATHYROIDECTOMY; PATIENT MONITORING; PROTEIN EXPRESSION; RENAL REPLACEMENT THERAPY; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY HYPERPARATHYROIDISM; TREATMENT DURATION; UREMIA; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; BLOOD; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; EDITORIAL;

DIETARY SUPPLEMENTS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; PARATHYROID HORMONE; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84861125405     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0048-1     Document Type: Review

References (54)

1. Mertens PR, Müller R (2010) Vitamin D and cardiovas-cular risk. Int Urol Nephrol 42(1):165-171
2. Ginde AA, Liu MC, Camargo CA Jr (2009) Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 169(6):626-632
3. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266-281
4. Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, Modlin RL, Adams JS (2007) Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 103(3-5):316
5. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(6 Suppl):1689S
6. Dusso AS, Thadhani R, Slatopolsky E (2004) Vitamin D receptor and analogs. Semin Nephrol 24(1):10-16
7. Rosen CJ (2011) Clinical practice. Vitamin D insuffi-ciency. N Engl J Med 364(3):248-254
8. Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22(4):477-501
9. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45(6):1026-1033
10. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W (2008) Independent association of low serum 25-hy-droxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168(12):1340-1349
11. Björkman M, Sorva A, Tilvis R (2009) Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr 48(2):160-166
12. Aloia JF, Talwar SA, Pollack S, Yeh J (2005) A random-ized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med 165(14):1618-1623
13. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, Holick MF, Hollis BW, Lamberg-Allardt C, McGrath JJ, Norman AW, Scragg R, Whiting SJ, Willett WC, Zittermann A (2007) The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85(3):649-650
14. Heaney RP (2005) The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97(1-2):13-19
15. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franz-son L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294(18):2336-2341
16. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7(5):439-443
17. Bindal ME, Taskapan H (2010) Hypovitaminosis D and insulin resistance in peritoneal dialysis patients. Int Urol Nephrol PMID: 14748937
18. Ambrus C, Almasi C, Berta K, Deak G, Marton A, Molnar MZ, Nemeth Z, Horvath C, Lakatos P, Szathmari M, Mucsi I (2010) Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol PMID: 20237846
19. Neves PL, Malho A, Cabrita A, Pinho A, Baptista A, Morgado E, Faísca M, Carrasqueira H, Silva AP (2010) Statins and vitamin D: a friendly association in pre-dialysis patients. Int Urol Nephrol 42(1):173-179
20. Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289(1):F8-F28
21. Mosekilde L (2005) Vitamin D and the elderly. Clin Endocrinol (Oxf) 62(3):265-281
22. Blair D, Byham-Gray L, Lewis E, McCaffrey S (2008) Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr 18(4): 375-382. [Erratum in: J Ren Nutr. 2009 Mar;19(2):195]
23. Michaud J, Naud J, Ouimet D, Demers C, Petit JL, Leblond FA, Bonnardeaux A, Gascon-Barré M, Pichette V (2010) Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 21(9):1488-1497
24. Hsu CH, Patel S (1992) Uremic plasma contains factors inhibiting 1 alpha-hydroxylase activity. J Am Soc Nephrol 3(4):947-952
25. Patel SR, Ke HQ, Vanholder R, Hsu CH (1994) Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafil-trate. Kidney Int 46(1):129-133
26. Cronin SC (2010) The dual vitamin D pathways: consid-erations for adequate supplementation. Nephrol Nurs J 37(1):19-26, 36 [quiz 27-8]
27. Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD (2011) Vitamin D supple-mentation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 6(1):50-62
28. Gracia-Iguacel C, Gallar P, Qureshi AR, Ortega O, Mon C, Ortiz M, Villarreal I, Garcia-Lacalle C, Olieta A, Sánchez M, Herrero JC, Vigil A, Lindholm B, Carrero JJ (2010) Vitamin D deficiency in dialysis patients: effect of dialysis modality and implications on outcome. J Ren Nutr 20(6):359-367
29. Bhan I, Burnett-Bowie SA, Ye J, Tonelli M, Thadhani R (2010) Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol 5(3):460-467
30. González EA, Sachdeva A, Oliver DA, Martin KJ (2004) Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24(5):503-510
31. Sahin G, Kirli I, Sirmagul B, Colak E, Yalcin AU (2009) Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients. Int Urol Nephrol 41(4):989-996
32. McAdam-Marx C, Yu J, Bouchard J, Aagren M, Brixner DI (2010) Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin. Curr Med Res Opin 26(1):191-201
33. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A (2010) Cholecalciferol supplementation in hemodialysis patients: effects on min-eral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 5(5):905-911
34. Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Du-kkipati R, Kovesdy CP (2010) Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calc-imimetics, alkaline phosphatase, and minerals. Kidney Int Suppl 117:S10-S21
35. Zisman AL, Hristova M, Ho LT, Sprague SM (2007) Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27(1):36-43
36. Binkley N, Ramamurthy R, Krueger D (2010) Low vitamin D status: definition, prevalence, consequences, and cor-rection. Endocrinol Metab Clin North Am 39(2):287-301
37. Trakarnvanich T, Chalapipat O, Disthabanchong S, Kura-thong S, Praditpornsilpa K, Stitchantrakul W, Chailurkit LO (2010) Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D defi-ciency. J Med Assoc Thai 93(8):885-891
38. Jean G, Vanel T, Terrat JC, Chazot C (2010) Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemo-dial Int 14(4):486-491
39. Rodriguez M, Martinez-Moreno JM, Rodríguez-Ortiz ME, Muñoz-Castañeda JR, Almaden Y (2011) Vitamin D and vascular calcification in chronic kidney disease. Kidney Blood Press Res 34(4):261-268
40. Stompór T (2007) An overview of the pathophysiology of vascular calcification in chronic kidney disease. Perit Dial Int 27(Suppl 2):S215-S222
41. Makin G, Lohnes D, Byford V, Ray R, Jones G (1989) Target cell metabolism of 1, 25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262(1):173-180
42. Jones G (2007) Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and non-classical actions of 1alpha, 25-dihydroxyvitamin D(3). Semin Dial 20(4):316-324
43. Sato T (2007) Renal bioactivation of vitamin D and its key modulators. Clin Calcium 17:686-690
44. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C (2008) Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1, 25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 110(1):c58-c65
45. Moe SM, Drüeke T, Lameire N, Eknoyan G (2007) Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 14(1):3-12
46. Al-Badr W, Martin KJ (2008) Vitamin D and kidney dis-ease. Clin J Am Soc Nephrol 3(5):1555-1560
47. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (113):S1-S130
48. NKF/KDOQI clinical practice guidelines for bone metab-olism and disease in chronic kidney disease. Availiable at: http://www.kidney.org/professionals/ KDOQI/guidelines- bone/index.htm
49. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD (2010) Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol 21(2):353-361
50. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD (2008) Vitamin D2 is as effective as vitamin D3 in main-taining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93(3):677
51. Armas LA, Hollis BW, Heaney RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89(11):5387-5391
52. Binkley N, Krueger D, Gemar D, Drezner MK (2008) Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 93(5):1804-1808 Epub 2008 Mar
53. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R (1998) Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68(4):854-858
54. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16(4):1115-1125